Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Plenary Session 3: Challenges and Opportunities of Genomic Based Clinical Trials

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5
Navigating the known and unknown challenges in the development of a selective NTRK inhibitor: The larotrectinib story
Keith T Flaherty
Massachusetts General Hosp. Cancer Ctr., Boston, MA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 28, 2017 10:20 AM-12:20 PM
NCI-MATCH: A new paradigm in the era of genomic oncology
Alice P. Chen
National Cancer Institute, Bethesda, MD, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 28, 2017 10:20 AM-12:20 PM
The National Lung Matrix Trial (NLMT): Challenges and opportunities
Gary Middleton
University of Birmingham, Birmingham, United Kingdom
from 2017 Molecular Targets and Cancer Therapeutics conference on October 28, 2017 10:20 AM-12:20 PM
Implementing genomic-driven basket clinical trials
José Baselga
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 28, 2017 10:20 AM-12:20 PM
Transcriptomic analysis of patient-derived xenografts reveals heterogeneity in human and mouse stroma/immune compartments
Henry Qixiang Li
Crown Bioscience, Inc., Beijing, China
from 2017 Molecular Targets and Cancer Therapeutics conference on October 28, 2017 10:20 AM-12:20 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5